Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader
NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era...
Clinical Trial
Cognizant Collaborates with Medidata to Provide Specialized Support for Life Sciences Clients
The organizations plan to support clients through expanded partnership and offer broader access to Medidata's AI-powered technologies to accelerate clinical...
Kinectrics and Isotopia Enter Agreement for Supply of Gadolinium-160 (Gd-160) to Support Production of Terbium-161 (Tb-161) for Advanced Radiotherapeutics
TORONTO, Jan. 30, 2025 /PRNewswire/ -- Kinectrics and Isotopia have announced a groundbreaking agreement under which Kinectrics will provide Isotopia...
UroMems Welcomes Medical Device Technology Leader Dan Rose as New Board Chairman
Rose brings medical device leadership and commercialization expertise to the company as it prepares to enter into U.S. and European...
Atreo and N-SIDE Announce Preferred Partnership to Optimize Clinical Trial Operations
Atreo's Partnership with N-SIDE Integrates Modern RTSM Solutions with Advanced Forecasting Capabilities SAN FRANCISCO, Jan. 30, 2025 /PRNewswire/ -- Atreo,...
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
Rebranding Signals Strategic Shift Beyond Biopharmaceuticals, Highlights Commitment to Technology, Artificial Intelligence and Shareholder Value WEXFORD, Pa., Jan. 30, 2025...
EVŌQ Nano Secures Strategic Investment From Global Business Leader & Philanthropist Tony Robbins to Advance Next-Generation Antimicrobial Nanoparticle Technology
SALT LAKE CITY, Jan. 30, 2025 /PRNewswire/ -- EVŌQ Nano, a nanoscience company that engineers novel nanoparticles for the life,...
ProofPilot to Host ‘Pharma Feud’ at the 16th Annual SCOPE Summit
NEW YORK, Jan. 30, 2025 /PRNewswire/ -- ProofPilot, the leading Clinical Experience Platform (CXP) that enhances engagement for sponsors, sites,...
Medicare Advantage Members Gain Access to Innovative Digital Therapeutics Through New Partnership
Kaia Health and eternalHealth Partner to Deliver Affordable, Effective Care to Seniors in Massachusetts and Arizona NEW YORK, Jan. 30, 2025...
Red Light Holland, in Partnership with FDA-Compliant and DEA-Registered Irvine Labs, Updates R&D Plan Focused On Commercialization
Toronto, Ontario--(Newsfile Corp. - January 30, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control
European patents expand coverage for both essential components of FemBloc for fallopian tube occlusion, resulting in non-surgical permanent contraceptionATLANTA, Jan....
Evaxion announces pricing of $10.8 million public offering
COPENHAGEN, Denmark, January 30, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
Allarity Therapeutics Announces Filing of Form 8-K Regarding Settlement Agreement in Principle with SEC
Boston (January 30, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to...
Adhere+ Launches Industry-First Spanish-Language Integration for Remote Therapeutic Monitoring
New Foreign Language Capability Enhances Healthcare Equity and Accessibility, Empowering Practices to Support Diverse Patient Populations WASHINGTON, Jan. 29, 2025 /PRNewswire/...
NervGen Pharma to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Vancouver, Canada--(Newsfile Corp. - January 29, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated...
Hemostemix Announces First Sales Orders for ACP-01
Calgary, Alberta--(Newsfile Corp. - January 29, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")...
Image Analysis Group Announces Release of DYNAMIKA V.7, their Award-Winning Cloud Platform for Clinical Trial Imaging
DYNAMIKA V.7 has achieved the British Standards Institute (BSI) surveillance audit certification following a recent SOC II Type I compliance...
Medrio’s Launches AI-Enabled Reporting, Tackling Increasing Data Challenges in Clinical Trials
SAN FRANCISCO, Jan. 29, 2025 /PRNewswire/ -- Medrio, a global leader in clinical trial technology, today announced the release of AI-enabled...
Potential Revolution in Healthcare Brewing, Powered by AI Innovation
USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, Jan. 29, 2025 /PRNewswire/ -- USA News...
More Than 200 Companies Advance Trial Management with Veeva CTMS
Biopharmas use leading CTMS for improved trial efficiency and collaboration PLEASANTON, Calif., Jan. 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE:...